Search research articles
Contact Us
Filters
Showing results (91-100 of 138) with videos related to
Page
of 14
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 1998
Clinical impact of pharmacokinetically-guided dose adaptation of 5-fluorouracil: results from a multicentric randomized trial in patients with locally advanced head and neck carcinomas
R Fety, F Rolland, M Barberi-Heyob, et al.
Gastroenterologie Clinique Et Biologique
|
April 12, 2003
[Concurrent concentrated radio-chemotherapy of epidermoid cancer of the esophagus. Long-term results of a phase II national multicenter trial in 122 non-operable patients (FFCD 8803)]
J F Seitz, C Milan, M Giovannini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 7, 2023
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
T Conroy, P Pfeiffer, V Vilgrain, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 10, 2006
A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer
F Bonnetain, O Bouché, P Michel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 29, 2015
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
M Ducreux, A Sa Cuhna, C Caramella, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 25, 2007
Assessing quality of life in patients with colorectal cancer: an update of the EORTC quality of life questionnaire
S Gujral, T Conroy, C Fleissner, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 29, 2013
Efficacy and safety of bevacizumab-based combination regimens in patients with previously untreated metastatic colorectal cancer: final results from a randomised phase II study of bevacizumab plus 5-fluorouracil, leucovorin plus irinotecan versus bevacizumab plus capecitabine plus irinotecan (FNCLCC ACCORD 13/0503 study)
M Ducreux, A Adenis, J-P Pignon, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 1, 1997
Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer
H Bleiberg, T Conroy, B Paillot, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 18, 2012
What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: surrogacy in question?
F Bonnetain, J F Bosset, J P Gerard, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 23, 2017
Health-related quality of life results from the PRODIGE 5/ACCORD 17 randomised trial of FOLFOX versus fluorouracil-cisplatin regimen in oesophageal cancer
C Bascoul-Mollevi, S Gourgou, M-P Galais, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 138) with videos related to
Sort By:
Page
of 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 1998
Clinical impact of pharmacokinetically-guided dose adaptation of 5-fluorouracil: results from a multicentric randomized trial in patients with locally advanced head and neck carcinomas
R Fety, F Rolland, M Barberi-Heyob, et al.
Gastroenterologie Clinique Et Biologique
|
April 12, 2003
[Concurrent concentrated radio-chemotherapy of epidermoid cancer of the esophagus. Long-term results of a phase II national multicenter trial in 122 non-operable patients (FFCD 8803)]
J F Seitz, C Milan, M Giovannini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 7, 2023
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
T Conroy, P Pfeiffer, V Vilgrain, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 10, 2006
A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer
F Bonnetain, O Bouché, P Michel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 29, 2015
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
M Ducreux, A Sa Cuhna, C Caramella, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 25, 2007
Assessing quality of life in patients with colorectal cancer: an update of the EORTC quality of life questionnaire
S Gujral, T Conroy, C Fleissner, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 29, 2013
Efficacy and safety of bevacizumab-based combination regimens in patients with previously untreated metastatic colorectal cancer: final results from a randomised phase II study of bevacizumab plus 5-fluorouracil, leucovorin plus irinotecan versus bevacizumab plus capecitabine plus irinotecan (FNCLCC ACCORD 13/0503 study)
M Ducreux, A Adenis, J-P Pignon, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 1, 1997
Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer
H Bleiberg, T Conroy, B Paillot, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 18, 2012
What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: surrogacy in question?
F Bonnetain, J F Bosset, J P Gerard, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 23, 2017
Health-related quality of life results from the PRODIGE 5/ACCORD 17 randomised trial of FOLFOX versus fluorouracil-cisplatin regimen in oesophageal cancer
C Bascoul-Mollevi, S Gourgou, M-P Galais, et al.
Page
of 14